IL37 and neoplasm: IL-12 induces IFN-γ-producing Th1 cells development and enhances cytotoxic, anti-microbial and anti-tumor responses; whereas IL-23 expands Th17 cells, which is mainly involved in the pathology of autoimmunity and chronic inflammatory disease [4].